Ftse Mib
33.674,33
1,37%
DAX
18.254,18
1,03%
S&P 500
5.473,17
-0,25%
NASDAQ
17.721,59
-0,79%
Bitcoin
65.015,74
0,07%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Tourmaline Bio Inc (TRML) Tourmaline Bio Inc (TRML) Notizie

Tourmaline Bio Inc

TRML
15,11
-0,44 (-2,83%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:54:58
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/6/202422:04EDGAR2Form 8-K - Current report
07/6/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202413:10GLOBETourmaline Bio to Present at the Jefferies Global Healthcare..
16/5/202413:00GLOBETourmaline Bio Initiates Clinical Development of TOUR006 for..
13/5/202422:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202413:15EDGAR2Form 8-K - Current report
13/5/202413:00GLOBETourmaline Bio Reports First Quarter 2024 Financial Results..
02/4/202413:00GLOBEAvalo Therapeutics Appoints Biotech Leaders to Board of..
19/3/202412:00GLOBETourmaline Bio Reports Fourth Quarter and Full Year 2023..
27/2/202413:30GLOBETourmaline Bio to Present at Upcoming Investor Conferences
15/2/202403:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202402:51EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/2/202422:22EDGAR2Form SC 13G - Statement of acquisition of beneficial..
01/2/202414:00GLOBETourmaline Bio to Present at the Guggenheim Healthcare Talks..
29/1/202422:01GLOBETourmaline Bio Announces Closing of $172.5 Million Public..
26/1/202422:12EDGAR2Form 8-K - Current report
26/1/202422:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
25/1/202413:00GLOBETourmaline Bio Announces Pricing of Public Offering of..
25/1/202403:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
24/1/202423:10EDGAR2Form 8-K - Current report
24/1/202422:05GLOBETourmaline Bio Announces Proposed Public Offering of Common..
08/1/202415:19EDGAR2Form 8-K - Current report
08/1/202413:00GLOBETourmaline Bio Announces Expected Upcoming Key Milestones..
15/12/202322:00GLOBETourmaline Bio added to the NASDAQ Biotechnology Index
14/12/202314:27EDGAR2Form 8-K - Current report
14/12/202313:30GLOBETourmaline Bio Appoints Dr. Clay Siegall as Chairman of the..
30/11/202314:25EDGAR2Form 8-K - Current report
01/11/202313:00GLOBETourmaline Bio to Present at Upcoming Investor Conferences
24/10/202302:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202302:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202302:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202302:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202302:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202302:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202300:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
19/10/202323:37GLOBETourmaline Bio Announces Closing of Merger with Talaris..
Apertura: 15,50 Min: 14,925 Max: 15,525
Chiusura: 15,55

La tua Cronologia

NASDAQ
TRML
Tourmaline Bio
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network